Clinton Group’s Idexx Laboratories IDXX Stock Holding History

Clinton Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-35,320	Closed	-$5.52M	–	421
2017 Q4	$5.52M	Sell	35,320 -2,389	-6%	-$376K	0.48%	64
2017 Q3	$5.86M	Buy	37,709 +26,601	+239%	+$4.21M	0.64%	48
2017 Q2	$1.79M	Buy	+11,108	New	+$1.8M	0.18%	176
2017 Q1	–	Sell	-2,003	Closed	-$235K	–	975
2016 Q4	$235K	Buy	+2,003	New	+$229K	0.01%	741
2016 Q2	–	Sell	-12,068	Closed	-$945K	–	950
2016 Q1	$945K	Buy	+12,068	New	+$869K	0.06%	439
2015 Q3	–	Sell	-26,297	Closed	-$1.69M	–	758
2015 Q2	$1.69M	Buy	26,297 +19,467	+285%	+$1.35M	0.24%	137
2015 Q1	$528K	Buy	6,830 +3,154	+86%	+$245K	0.14%	231
2014 Q4	$273K	Sell	3,676 -4,310	-54%	-$302K	0.09%	358
2014 Q3	$470K	Buy	+7,986	New	+$505K	0.19%	172
2014 Q2	–	Sell	-4,702	Closed	-$285K	–	366
2014 Q1	$285K	Buy	+4,702	New	+$280K	0.11%	275

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Clinton Group's IDXX Position: Q1 2018 in Review

Clinton Group sold out of Idexx Laboratories (IDXX) in Q1 2018, closing a stake of 35,320 shares — an estimated $5.52M sold.

Clinton Group first reported a position in IDXX in Q1 2014 and held it in 10 quarters. The position peaked at $5.86M in Q3 2017. 646 funds tracked by Wall St. Rank hold IDXX as of Q1 2018.

Clinton Group reported no remaining Idexx Laboratories position as of Q1 2018 after selling out during the quarter.
Clinton Group sold 35,320 Idexx Laboratories shares in Q1 2018, an estimated $5.52M.
Clinton Group first reported a position in Idexx Laboratories in Q1 2014 and held it in 10 quarters.
Clinton Group's Idexx Laboratories position peaked at $5.86M in Q3 2017.
646 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2018.

Based on Clinton Group's 13F filing for Q1 2018, filed 14 May 2018.